Technology

Visa Signs $2.4 Billion Deal to Acquire Israel's BioCatch

Published

Courtroom-sketch editorial illustration of 13 BioCatch team members posed in two rows around a tan leather sofa in a warm wood-paneled office.

Visa signed a definitive agreement to acquire Israeli fraud-intelligence company BioCatch from Permira-advised funds and other shareholders for $2.4 billion in cash. BioCatch uses artificial intelligence and behavioral signals such as keystrokes, touch gestures and device handling to distinguish legitimate users from fraudsters in real time. The company says its technology protects 1.8 billion devices and 760 million users across more than 350 banking clients in 21 countries. The transaction remains subject to customary closing conditions and regulatory approvals, with completion expected by the end of Visa's fiscal second quarter of 2027.

Sources

Primary sources:1Secondary sources:234

Related stories

  1. Deel Acquires Israeli Deepfake-Detection Startup Clarity
  2. Zenity Raises $125 Million Series C for AI Agent Security
  3. Tal Inbar Named Apple Israel CEO as Rony Friedman Takes Global Chip-AI Role
  4. Bloom Security Raises $20 Million Seed Round for AI-Native Endpoint Protection
  5. Can-Fite Submits First Piclidenoson Phase 2 Protocol for Lowe Syndrome

Something went wrong

We couldn't complete that action. Check your connection and try again.